<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">William W. Seeley</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>UCSF Memory and Aging Center</td>
</tr>
<tr>
<td class="label">Country</td>
<td>United States</td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>Alzheimer's Disease, Frontotemporal Dementia</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Connectivity-based Modeling, Selective Neuronal Vulnerability, Tau Imaging</td>
</tr>
</table>
William W. Seeley
Overview
William W. Seeley plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
William W. Seeley is a leading researcher in the field of neurodegenerative diseases, affiliated with UCSF Memory and Aging Center. Their work focuses on Neurodegeneration, connectivity-based modeling, selective vulnerability, network breakdown, contributing significantly to our understanding of disease mechanisms and diagnostic approaches.
Research Focus
Disease Areas
- [Alzheimer's Disease](/diseases/alzheimers-disease), [Frontotemporal Dementia](/diseases/frontotemporal-dementia), [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
...<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">William W. Seeley</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>UCSF Memory and Aging Center</td>
</tr>
<tr>
<td class="label">Country</td>
<td>United States</td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>Alzheimer's Disease, Frontotemporal Dementia</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Connectivity-based Modeling, Selective Neuronal Vulnerability, Tau Imaging</td>
</tr>
</table>
William W. Seeley
Overview
William W. Seeley plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
William W. Seeley is a leading researcher in the field of neurodegenerative diseases, affiliated with UCSF Memory and Aging Center. Their work focuses on Neurodegeneration, connectivity-based modeling, selective vulnerability, network breakdown, contributing significantly to our understanding of disease mechanisms and diagnostic approaches.
Research Focus
Disease Areas
- [Alzheimer's Disease](/diseases/alzheimers-disease), [Frontotemporal Dementia](/diseases/frontotemporal-dementia), [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
Mechanisms of Interest
- Connectivity-based Modeling, Selective Neuronal Vulnerability, [Tau](/proteins/tau) Imaging
Key Publications
2020. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. [DOI:10.1093/brain/awaa276](https://doi.org/10.1093/brain/awaa276)
2019. Patient-Tailored, Connectivity-Based Forecasts of Spreading Brain Atrophy. [DOI:10.1016/j.neuron.2019.08.037](https://doi.org/10.1016/j.neuron.2019.08.037)
2020. Positron Emission Tomography Imaging With 18Fflortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. [DOI:10.1001/jamaneurol.2020.0528](https://doi.org/10.1001/jamaneurol.2020.0528)
2012. Predicting regional neurodegeneration from the healthy brain functional connectome. [DOI:10.1016/j.neuron.2012.03.004](https://doi.org/10.1016/j.neuron.2012.03.004)
Collaborations
Dr. Seeley has established productive collaborations with researchers across multiple institutions, particularly in the field of network-based neurodegeneration research. His work with the Alzheimer's Disease Neuroimaging Initiative (ADNI) has advanced understanding of how functional brain networks degenerate in Alzheimer's disease. He has also collaborated with researchers at UCSF and other leading institutions to validate network vulnerability hypotheses.
Training and Mentorship
As a professor at UCSF, Dr. Seeley has mentored numerous graduate students and postdoctoral fellows in neuroimaging techniques and network analysis methods. His training program emphasizes the integration of functional MRI, structural MRI, and PET imaging to understand brain network changes in neurodegeneration.
Research Contributions
Dr. Seeley's most significant contribution has been the development and validation of the network degeneration hypothesis. This framework proposes that neurodegenerative diseases target specific large-scale brain networks, leading to characteristic patterns of dysfunction and atrophy. His work has demonstrated that the pattern of brain atrophy in Alzheimer's disease corresponds to the layout of the default mode network, providing evidence for the network-based spread of pathology.
Future Directions
Future research directions include:
- Investigating the mechanisms underlying network vulnerability
- Developing network-based biomarkers for early detection
- Exploring therapeutic targets that can protect vulnerable networks
- Integrating multimodal imaging for improved diagnostic accuracy
See Also
- [UCSF Memory and Aging Center](/institutions/ucsf-memory-and-aging-center)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Neuroimaging](/mechanisms/neuroimaging-methodology)
- [PET Imaging](/mechanisms/pet-imaging)
External Links
- [PubMed Search](https://pubmed.ncbi.nlm.nih.gov/?term=William+W.+Seeley)
His research program has provided crucial insights into the selective vulnerability of specific brain networks in neurodegenerative diseases. By combining advanced neuroimaging techniques with detailed clinical characterization, Dr. Seeley has mapped how different diseases target distinct neural networks. This work has implications for early diagnosis, prognosis, and the development of targeted therapeutic interventions.
The network degeneration framework developed by Dr. Seeley has become a leading model in the field of neurodegeneration. It explains why different neurodegenerative diseases produce distinct clinical syndromes based on which brain networks are affected. This conceptual framework has guided numerous research studies and has influenced clinical trial design by helping to identify optimal outcome measures.
Overview
William W. Seeley plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of William W. Seeley has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Recent Research (2024-2026)
Recent PubMed-indexed publications:
[G-protein-coupled receptor ADGRG1 drives a protective microglial state in Alzheimer's disease through MYC activation.](https://pubmed.ncbi.nlm.nih.gov/40713954/) Neuron. 2024.
[TDP-43 pathology in Alzheimer's disease is associated with increased CSF neurofilament light chain and worse clinical outcome.](https://pubmed.ncbi.nlm.nih.gov/40280976/) Brain. 2024.
[Network connectivity and tau pathology in primary age-related tauopathy and Alzheimer's disease.](https://pubmed.ncbi.nlm.nih.gov/39379761/) Brain. 2024.
[Microglial activation and tau pathology in Alzheimer's disease: a multimodal PET study.](https://pubmed.ncbi.nlm.nih.gov/40949955/) Ann Neurol. 2025.
[TDP-43 co-pathology and associations with amyloid, tau, and neurodegeneration in community-based cohorts.](https://pubmed.ncbi.nlm.nih.gov/41720779/) Acta Neuropathol. 2025.Research Contributions
Mermaid diagram (expand to render)
References
[Unknown, 2020. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases (2020)](https://doi.org/10.1093/brain/awaa276)
[Unknown, 2019. Patient-Tailored, Connectivity-Based Forecasts of Spreading Brain Atrophy (2019)](https://doi.org/10.1016/j.neuron.2019.08.037)
[DOI:10.1001/jamaneurol.2020.0528](https://doi.org/10.1001/jamaneurol.2020.0528)
[Unknown, 2012. Predicting regional neurodegeneration from the healthy brain functional connectome (2012)](https://doi.org/10.1016/j.neuron.2012.03.004)